Site Editor

Sandy Srinivas, MD

Advertisement

Advertisement

News

Using Virtual Reality Models to Improve Surgical Decision-Making in Prostate Cancer

Medical Literature

Can the Number of Positive Pelvic Lymph Nodes Guide Adjuvant Radiation Therapy for Prostate Cancer?

News

FDA Approves Darolutamide Combination for Metastatic Hormone-Sensitive Prostate Cancer

Medical Literature

Oligometastatic Hormone-Sensitive Prostate Cancer: Androgen-Deprivation and Radiation Therapies

Medical Literature

Adding Darolutamide to Standard Treatment in Metastatic, Hormone-Sensitive Prostate Cancer

Medical Literature

Researchers Offer Evidence That Prostate Cancer Biology May Differ by Racial Ancestry

Medical Literature

Enzalutamide Monotherapy: Active Surveillance Alternative in Low- or Intermediate-Risk Prostate Cancer?

Michael J. Morris, MD: Can Lutetium-177–PSMA-617 Plus Standard of Care Improve Outcomes in Advanced Prostate Cancer?

Sandy Srinivas, MD, on Balancing Quality of Life and Survival When Making Decisions About Prostate Cancer Treatment

View More

Advertisement

JNCCN Spotlights

Docetaxel (Castration-Naive Metastatic Prostate Cancer)

(UPDATE) Enzalutamide (Xtandi®)

Degarelix (Injectable GnRH Antagonist)

(UPDATE) Apalutamide in Prostate Cancer

View More

More

News

Randomized Trial to Focus on Lifestyle Changes During Radiotherapy for Prostate Cancer

Using Virtual Reality Models to Improve Surgical Decision-Making in Prostate Cancer

Combining Tyrosine Kinase and PD-L1 Inhibitors to Treat Metastatic Prostate Cancer

Genomic Studies Offer Insight Into Progression of Prostate Cancer After Hormonal Therapy

Are LHRH Antagonists Indicated for Patients With Prostate Cancer at High Cardiovascular Risk?

Digital Health Coaching for Patients With Prostate Cancer: Findings of a Pilot Study

FDA Grants Priority Review to Olaparib-Based Combination for Metastatic Castration-Resistant Prostate Cancer

FDA Approves Darolutamide Combination for Metastatic Hormone-Sensitive Prostate Cancer

View More

Advertisement

Published

Medical Literature

Mortality Risk and PSA Failure in Localized Versus Locally Advanced Prostate Cancer

Prognostic Factors for Decisional Regret Regarding Treatment in Localized Prostate Cancer

Is Radiotherapy of Benefit for Men With Prostate Cancer and Inflammatory Bowel Disease?

Metastatic Castration-Resistant Prostate Cancer: Reconsidering the Role of Olaparib

View More

Ongoing

CE Activities

Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting

Talk to Someone: Explore Talking to Patients About Prostate Cancer Treatment

How Will You Manage These Patients With Prostate Cancer? Practice Your Skills in This Virtual Patient Simulation

Patient Simulations in Personalized Planning for Prostate Cancer

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

City of Hope

Dana-Farber Cancer Institute

View More

Resources

For Your Patients

Urology Care Foundation

Cancer Support Community

Prostate Cancer Foundation

NCCN Guidelines for Patients®: Prostate Cancer: Early Stage

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2022 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.